1. Home
  2. INTG vs RLMD Comparison

INTG vs RLMD Comparison

Compare INTG & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTG
  • RLMD
  • Stock Information
  • Founded
  • INTG 1965
  • RLMD 2004
  • Country
  • INTG United States
  • RLMD United States
  • Employees
  • INTG N/A
  • RLMD N/A
  • Industry
  • INTG Building operators
  • RLMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • INTG Real Estate
  • RLMD Health Care
  • Exchange
  • INTG Nasdaq
  • RLMD Nasdaq
  • Market Cap
  • INTG 24.8M
  • RLMD 22.0M
  • IPO Year
  • INTG N/A
  • RLMD N/A
  • Fundamental
  • Price
  • INTG $13.40
  • RLMD $0.67
  • Analyst Decision
  • INTG
  • RLMD Buy
  • Analyst Count
  • INTG 0
  • RLMD 3
  • Target Price
  • INTG N/A
  • RLMD $5.00
  • AVG Volume (30 Days)
  • INTG 4.0K
  • RLMD 478.7K
  • Earning Date
  • INTG 05-15-2025
  • RLMD 08-06-2025
  • Dividend Yield
  • INTG N/A
  • RLMD N/A
  • EPS Growth
  • INTG N/A
  • RLMD N/A
  • EPS
  • INTG N/A
  • RLMD N/A
  • Revenue
  • INTG $61,597,000.00
  • RLMD N/A
  • Revenue This Year
  • INTG N/A
  • RLMD N/A
  • Revenue Next Year
  • INTG N/A
  • RLMD N/A
  • P/E Ratio
  • INTG N/A
  • RLMD N/A
  • Revenue Growth
  • INTG 6.76
  • RLMD N/A
  • 52 Week Low
  • INTG $10.18
  • RLMD $0.24
  • 52 Week High
  • INTG $22.84
  • RLMD $4.47
  • Technical
  • Relative Strength Index (RSI)
  • INTG 57.11
  • RLMD 52.84
  • Support Level
  • INTG $11.17
  • RLMD $0.67
  • Resistance Level
  • INTG $11.85
  • RLMD $0.72
  • Average True Range (ATR)
  • INTG 0.71
  • RLMD 0.08
  • MACD
  • INTG 0.30
  • RLMD -0.03
  • Stochastic Oscillator
  • INTG 46.60
  • RLMD 40.29

About INTG Intergroup Corporation (The)

The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: